Skip to main content
. 2021 Jun 16;118(25):e2025299118. doi: 10.1073/pnas.2025299118

Fig. 1.

Fig. 1.

Schematic illustration of SubMAPP. (A) Subcellular targeting of bioorthogonally activatable PL enzymes, photoTurbo and chemoTurbo variants, are created by genetically replacing the catalytic lysine residue with photo-/chemo-caged lysine analogs. Temporal-gated PL enzyme activation and subcellular proteomic labeling can be achieved by in situ decaging. Biotinylated proteins subsequently undergo an orthogonal pull-down pipeline to yield digested phosphopeptides, which were subjected to quantitative MS analysis. (B) Schematic illustration of photoTurbo activation. The photo-caged lysine analog (ONPK) can be genetically and site-specifically incorporated into Turbo in place of the conserved catalytic lysine residue (K182). Upon 365 nm photolysis, photoTurbo is rapidly activated, thus triggering the enzymatic generation of biotin-AMP from biotin and ATP. (C) Chemical structures of photo-caged and chemo-caged unnatural amino acids.